Oklahoma researchers found the hormone FGF21 targets the same brain region as GLP-1 drugs, but works by boosting metabolic ...

The FDA’s approval of the new weight loss pill Orforglipron marks a shift in the world of obesity treatment. The change may affect not only efficacy, but primarily adherence to treatment.

Twelve million people lost coverage for Zepbound over the last year. The same number of people lost coverage for Wegovy, ...

In a US societal-perspective lifetime simulation based on SURMOUNT-5 data, tirzepatide was projected to deliver lower total ...

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type of heart failure experience weakened heart muscles, and that losing weight ...

While outcomes were somewhat attenuated in elderly patients, benefits were consistent across sex and age. These findings ...

Obesity is a chronic health condition that affects over 40% of U.S. adults and can lead to other conditions like type 2 diabetes and heart disease. Common types of therapy for obesity include ...

Most fat stores energy; the body's brown fat does the opposite. Unlike the white fat that accumulates just under our skin, ...

BMI z-score reduction of at least 0.25 is associated with lower risks for type 2 diabetes and hypertension in children with MHO and MUO.

Obesity may be a contributing factor in more than 10% of infection-related deaths, a new study reveals. The researchers analyzed medical data from nearly 550,000 adults in Finland and the U.K. over a ...

A global commission of 56 medical experts is proposing a major overhaul of how obesity is defined and diagnosed, going beyond just body mass index. Vadym - stock.adobe.com Now, a global commission of ...

GLP-1 receptor agonists reduced asthma exacerbations among adults with asthma and excess weight but without diabetes in ...